Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lorazepam for patient satisfaction in flexible bronchoscopy
NCT01121055Phase 4Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Mar 2010
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lorazepam in anxiety disorder (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Patient satisfaction. Status: unknown.
02
Drugs
lorazepam
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT01121055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01121055.